-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-01
ZLSSF:NSD- (USD)
COMMON STOCK | Shell Companies |
Last Closing
USD 10.85Change
0.00 (0.00)%Market Cap
N/AVolume
N/A
N/A
Verdict
Values as of: 2025-04-01
COMMON STOCK | Shell Companies |
Last Closing
USD 10.85Change
0.00 (0.00)%Market Cap
N/AVolume
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
ANSC | Agriculture & Natural Solution.. |
N/A |
USD 0.46B |
GPAT | GP-Act III Acquisition Corp. C.. |
N/A |
USD 0.37B |
CCIR | Cohen Circle Acquisition Corp... |
N/A |
USD 0.36B |
ALDF | Aldel Financial II Inc. Class .. |
N/A |
USD 0.30B |
GSRT | GSR III Acquisition Corp. Ordi.. |
N/A |
USD 0.29B |
DRDBU | Roman DBDR Acquisition Corp. I.. |
N/A |
USD 0.27B |
SLAMF | Slam Corp. |
N/A |
USD 0.27B |
HLXB | Helix Acquisition Corp. II Cla.. |
N/A |
USD 0.26B |
KFIIU | K&F Growth Acquisition Corp. I.. |
N/A |
USD 0.26B |
IVCB | Investcorp Europe Acquisition .. |
N/A |
USD 0.21B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
HOG:CA | 8.28 % | 0.64 % |
N/A |
N/A | |
XUT:CA | iShares S&P/TSX Capped Ut.. | 7.65 % | 0.62 % |
N/A |
CAD 0.37B |
ZUT:CA | BMO Equal Weight Utilitie.. | 7.06 % | 0.60 % |
N/A |
CAD 0.51B |
FCAN | 4.03 % | 0.80 % |
N/A |
N/A | |
FXM:CA | First Asset Morningstar C.. | 3.73 % | 0.67 % |
N/A |
CAD 0.30B |
CEMT:F | iShares Edge MSCIope Size.. | 0.00 % | 0.00 % |
N/A |
USD 0.02B |
EXH8:XETRA | iShares (DE) I - iShares .. | 0.00 % | 0.00 % |
N/A |
USD 0.01B |
QUED:XETRA | BNP Paribas Easy ESG Equi.. | 0.00 % | 0.00 % |
N/A |
N/A |
QUEU:XETRA | BNP Paribas Easy ESG Equi.. | 0.00 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Shell Companies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike